Navigation Links
Maxilip Lip Plumper Named CEW Beauty Insider's Choice Awards 2013 Finalist
Date:4/10/2013

MIAMI LAKES, Fla., April 10, 2013 /PRNewswire-iReach/ -- On Friday, April 5, the professional organization Cosmetic Executive Women (CEW) announced the Maxilip Lip Plumper as a finalist for the 2013 Beauty Insider's Choice Award in the lip treatment category.  Maxilip, a brand of Vivant Pharmaceuticals, LLC, is competing against industry heavies Vaseline, Nivea, Aquaphor, Fresh, Inc. and Burt's Bees.

(Photo: http://photos.prnewswire.com/prnh/20130410/CG90589)

"This prestigious nomination is a great honor and speaks to the quality of our product," says CEO Kelly Fulton-Kendrick . "That Maxilip was voted in by CEW members is amazing when you consider the breadth of beauty and cosmetic products that were entered into the competition and the long-standing market-domination that the other nominees in our category enjoy."

The Maxilip Lip Plumper was sampled and given away to CEW members at the Beauty Insider's Choice Awards Product Demo, held at the Metropolitan Pavilion in New York on March 6. More than 2,300 insiders from the world of beauty attended the event that highlighted the industry's best and brightest innovations from the past year.

The 194 total finalists from the more than 650 product entries were chosen by votes cast online by CEW members. The next step is a final evaluation by the CEW Board of Governors, which will occur during the next few weeks. All winners will be announced at a special luncheon to be held at the Waldorf-Astoria Hotel in Manhattan on May 17.

ABOUT VIVANT PHARMACEUTICALS, LLC
Vivant Pharmaceuticals, LLC is a family-owned company comprised of the Vivant Skin Care and Maxilip brands, with more than 40 years' experience in the research, formulation and development of high-quality, corrective and preventative skin care products. Located at 5753 NW 158 Street in Miami Lakes, FL, the company began selling its line to the direct-to-retail market in August 2011 after having been an exclusively wholesale business since 1990. Prior to this shift, their products were successfully sold through doctors' offices and medical spas.

The Vivant research and development team, led by author, noted speaker and Lead Formulating Consultant Dr. James E. Fulton , MD, Ph.D., the co-developer of Retin A®, has created a powerful and cost-effective line of skin care products. Vivant also supports their skin care professional distributors with ongoing education, seminars, suggested protocols and product manuals. In addition to growing the wholesale end of its business model, Vivant is now actively pursuing additional retail and international opportunities.

For more information and to shop online, visit www.VivantSkinCare.com, like them on www.Facebook.com/VivantSkin, follow them on www.Twitter.com/VivantSkinCare.com and www.Pinterest.com/VivantSkin and view their videos at www.youtube.com/VivantSkin. Call them toll-free at 855.4.VIVANT (855.484.8268).

Media Contact:

Michael Mut, Vivant Skin Care, 7864262277, michael@vivantskincare.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Vivant Skin Care
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Doug Bonacum of Kaiser Permanente Named to List of 50 Experts Leading the Field of Patient Safety
2. Xenon Named Life Sciences Company of the Year by LifeSciences British Columbia
3. Covis Pharmaceuticals, Inc Named US Distributor For Five Additional Products
4. SynCardias Companion 2 Driver Named a Finalist in the Medical Design Excellence Awards
5. Ultroz Elite Wearable Ultrasonic Therapy System was Named as Finalist in the 2013 Medical Design Excellence Awards
6. Nick Pace Named EVP -- Operations, Compliance, and Regulatory
7. Best Healthcare Websites of 2013 to be Named by Web Marketing Association in 17th Annual WebAward Competition
8. Deacom Named a Finalist for 2013 SmartCEO Voltage Awards
9. DelMar Pharma Named to Rocket Builders 2013"Ready to Rocket" List
10. Steven Ek Named President and CEO of Arthrosurface
11. Henry Schein Named to FORTUNEs List of Most Admired Companies for 12th Consecutive Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC ... by obtaining investment capital for emerging technology companies. SCP has delivered investment ... resulted in more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... human induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces ... Medium. The PluriQ™ G9™ Gene Editing System is a complete system ...
Breaking Medicine News(10 mins):